The Different Conformational States of Tissue Transglutaminase Have Opposing Affects on Cell Viability

This publication has 54 references indexed in Scilit:

• A Mechanism for the Upregulation of EGF Receptor Levels in Glioblastomas
  Cell Reports, 2013
• Transglutaminase 2: A molecular Swiss army knife
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2012
• Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells
  Proceedings of the National Academy of Sciences, 2011
• EGF potentiated oncogenesis requires a tissue transglutaminase-dependent signaling pathway leading to Src activation
  Proceedings of the National Academy of Sciences, 2010
• The molecular basis for the regulation of the cap-binding complex by the importins
  Nature Structural & Molecular Biology, 2009
• Tissue Transglutaminase Is an Essential Participant in the Epidermal Growth Factor-stimulated Signaling Pathway Leading to Cancer Cell Migration and Invasion
  Journal of Biological Chemistry, 2009
• GTP-Binding-Defective Forms of Tissue Transglutaminase Trigger Cell Death
  Biochemistry, 2007
• Transglutaminase 2 inhibitors and their therapeutic role in disease states
  Pharmacology & Therapeutics, 2007
• Two isoforms of tissue transglutaminase mediate opposing cellular fates
  Proceedings of the National Academy of Sciences, 2006
• Importance of Ca²⁺-Dependent Transamidation Activity in the Protection Afforded by Tissue Transglutaminase against Doxorubicin-Induced Apoptosis
  Biochemistry, 2006